Tumor-derived factors, such as G-CSF (also known as CSF3), GM-CSF (also known as CSF2), and IL-6 drive this myeloid bias and increase the circulating and tumor-infiltrating MDSC population, which accelerates tumor progression by suppressing T cell responses and releasing metabolic factors (28). Here, IL6 is linked to neoplasm.